2016 annual financial data
Seres Therapeutics 2016 Net margin
Seres Therapeutics 2016 net margin with verified reported values.
Direct answer
Net margin was -420.74%.
Operating income was -92,839,000 USD and net income was -91,579,000 USD.
Operating cash flow was 43,921,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 21,766,000 USD
- Operating income
- -92,839,000 USD
- Net income
- -91,579,000 USD
- Operating cash flow
- 43,921,000 USD